Evaluating the Benefits of Curcumin(Turmeric) and Tetracycline in Gum Disease Treatment: A Clinical Study

EVALUATION OF CURCUMIN CHIP AND TETRACYCLINE FIBERS AS ADJUNCT TO SCALING AND ROOT PLANING –A CLINICAL STUDY - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076536

Enrollment

Registered

2024-11-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Curcumin chip: Curcumin chip is placed as Local drug delivery as adjunct to scaling and root planing for 15 patients Control Intervention1: Tetracycline fibers: Tetracycline fibers are

Eligibility

Inclusion criteria

Inclusion criteria: Probing depth 5-8mm Patients with good systemic health. Patients who had not received any surgical or non-surgical periodontal therapy in the past 6 months. Patients who had not received antibiotic therapy in the past 6 months.

Exclusion criteria

Exclusion criteria: History of using anti-microbial mouthrinses within 2 months of the baseline visit Patients having a history of allergy to tetracycline; lidocaine. Pregnant woman and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Probing pocket depth Gingival index Bleeding on probing Plaque index and Clinical attachment levelTimepoint: 1 month and 3 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactSanjana J

SRM kattankulathur dental college,Chennai.

ravishak@srmist.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026